Following on from the success of ICA-2012, BIT Congress Inc. is proud to announce that the 5th Annual International Congress of Antibodies (ICA-2013) will be held during March 18-20, 2013 in Beijing, China with the theme “Antibody R & D and Human Health”.
With the development and improvement of modern biotechnology in recent years, antibody engineering and technologies have become one of the main stream biomedical areas and play a pivotal role in pharmaceutical and medical industries. Initiated by BIT Life Sciences in 2008, ICA offers a unique meeting place for professionals from all over the world to share scientific information, seek research collaborations, foster new business opportunities, and discuss how to prevent and treat disease. During 4 years of successful running of ICA, it has attracted more than 1600 participants from 56 countries, and has been the most definitive antibody event in Asia.
The coming new ICA-2013 will be held together with WCV-2013(World Congress of Vaccines), it will be an outstanding experience, both scientifically and socially. We will endeavor to provide a better platform for antibody researchers, clinicians, epidemiologists, microbiologists, immunologists, molecular biologists, public health officials, representatives from pharmaceutical and biotechnology industries, and policy makers to discuss the latest developments in the fields of vaccines and antibodies in order to work towards saving and enhancing lives. Besides, The congress venue Hangzhou is one of the most famous, beautiful and romantic tourist destination in China, and there will be an exciting social program lined up which will allow delegates opportunities to network whilst enjoying the fantastic stay Hangzhou has to offer.
Attendance cost: $1399
Event organizer: BIT Congress, Inc.